The Outcome of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) in the R-CHOP Treatment Era

被引：32
|
作者：
Savage, Kerry J. [1 ]
Yenson, Paul R. [2 ]
Shenkier, Tamara [1 ]
Klasa, Richard [1 ]
Villa, Diego [1 ]
Goktepe, Ozge
Steidl, Christian [3 ]
Slack, Graham W. [3 ]
Gascoyne, Randy D. [3 ]
Connors, Joseph M. [1 ]
Sehn, Laurie H. [1 ]
机构：
[1] British Columbia Canc Agcy, Ctr Lymphoid Canc, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada
[2] Univ British Columbia, Div Hematol, Dept Internal Med, Vancouver, BC V5Z 1M9, Canada
[3] British Columbia Canc Agcy, Dept Pathol, Ctr Lymphoid Canc, Vancouver, BC V5Z 4E6, Canada
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.303.303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
303
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOP
    Mondello, Patrizia
    Mian, Michael
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 333 - 344
  • [12] Diffuse large B-cell lymphoma: R-CHOP forever?
    Jedrzejczak, Wieslaw W.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (10): : 713 - 714
  • [13] Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment
    Felicitas Hitz
    J. M. Connors
    R. D. Gascoyne
    P. Hoskins
    A. Moccia
    K. J. Savage
    L. H. Sehn
    T. Shenkier
    D. Villa
    R. Klasa
    Annals of Hematology, 2015, 94 : 1839 - 1843
  • [14] PROGNOSTIC FACTORS FOR THE OUTCOME OF PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL) UNDER CHEMOTHERAPY WITH RITUXIMAB-CHOP (R-CHOP) WITH OR WITHOUT RADIOTHERAP
    Vassilakopoulos, T.
    Angelopoulou, M.
    Pangalis, G.
    Katsigiannis, A.
    Papageorgiou, S.
    Vrakidou, E.
    Poziopoulos, C.
    Constantinou, N.
    Repoussis, P.
    Dimopoulou, M.
    Kokoris, S.
    Dimou, M.
    Kyrtsonis, M.
    Panayiotidis, P.
    Dervenoulas, J.
    Roussou, P.
    Beris, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 116 - 116
  • [15] Favorable Outcome of Primary Mediastinal Large B-Cell Lymphoma Patients Treated with Sequential R-CHOP/R-ICE Regimen Omitting Radiation
    Goldschmidt, Neta
    Paltiel, Ora B.
    Ben Yehuda, Dina
    Kleinstern, Geffen
    Gural, Alexander
    Libster, Diana
    Lavie, David
    Gatt, Moshe E.
    BLOOD, 2015, 126 (23)
  • [16] Outcome of patients with primary refractory diffuse large B cell lymphoma after R-CHOP treatment
    Hitz, Felicitas
    Connors, J. M.
    Gascoyne, R. D.
    Hoskins, P.
    Moccia, A.
    Savage, K. J.
    Sehn, L. H.
    Shenkier, T.
    Villa, D.
    Klasa, R.
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1839 - 1843
  • [17] Excellent outcome with rituximab-CHOP (R-CHOP) combined with radiotherapy (RT) in primary mediastinal large B-cell lymhoma (PMLBCL)
    Vassilakopoulos, TP
    Angelopoulou, MK
    Galani, Z
    Sachanas, S
    Katsigiannis, A
    Dimopoulou, MN
    Kokoris, SI
    Michalis, E
    Dimitriadou, EM
    Siakantaris, MP
    Kontopidou, FN
    Kalpadakis, C
    Sarantopoulos, A
    Korkolopoulou, P
    Roussou, P
    Pangalis, GA
    BLOOD, 2005, 106 (11) : 275A - 275A
  • [18] Comparison Between R-CHOP Vs R-CHOP Plus Etoposide in Untreated Patients with Primary Mediastinal B-Cell Lymphoma: Preliminary Findings
    Rodrigues Maciel, Felipe Vieira
    Szor, Roberta Shcolnik
    Levy, Debora
    Santucci, Rodrigo
    Pereira, Juliana
    BLOOD, 2014, 124 (21)
  • [19] R-CHOP in Primary Mediastinal B-Cell Lymphoma (PMBL): Results from the UK NCRI R-CHOP 14 v 21 Trial
    Gleeson, Mary
    Hawkes, Eliza A.
    Cunningham, David
    Chadwick, Nick
    Counsell, Nick
    Lawrie, Anthony
    Jack, Andrew
    Smith, Paul
    Mouncey, Paul
    Pocock, Christopher
    Ardeshna, Kirit
    Radford, John
    McMillan, Andrew
    Davies, John
    Turner, Deborah
    Kruger, Anton
    Johnson, Peter W. M.
    Gambell, Joanna
    Linch, David
    BLOOD, 2015, 126 (23)
  • [20] Dose-Adjusted EPOCH-R is Superior to R-CHOP in Frontline Treatment of Mediastinal Large B-Cell Lymphoma
    Ma'koseh, Mohammad
    Yaseen, Abeer
    Abu Abed, Nebras
    Shahin, Omar
    Abufara, Alaa
    Halahleh, Khalid
    Al-Rwashdeh, Mohammad
    Rahman, Zaid Abdel
    Alyaqoub, Maram
    Al-rabi, Kamal
    Abdel-Razeq, Hikmat
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S488 - S488
12345